Less is More: The Promise of Weekly Insulin in Type 2 Diabetes

Explore how weekly insulin innovations are reshaping T2D treatment through an evidence-based review of ultra-long-acting basal insulin and clinical trial insights. Tailored specifically for primary care physicians (PCPs), a 15-minute pre-work on-demand session offers practical strategies for integrating these advances into your practice.

Then dive into the 60-minute on-demand activity, developed in collaboration with the ACOFP, to deepen your understanding of innovative insulin therapies for type 2 diabetes. Through a detailed exploration of cutting-edge clinical practices, this activity provides actionable strategies for seamlessly integrating weekly insulin options into patient care.

Key Topics Include:

• Insights into ultra-long-acting basal insulin for T2D
• Best practices for initiating and managing weekly insulin
• Clinical considerations for optimizing patient outcomes
• Describing the place of novel insulin therapies, including once-weekly basal insulin, in treating T2D
• Developing strategies for initiating, dosing, and titrating once-weekly basal insulin for T2D
• Examining the consequences of delaying initiation and intensification of basal insulin in eligible patients
• Communicating to your patients the advantages of once-weekly basal insulin, considering patient concerns about weight gain and hypoglycemia

Stay ahead in diabetes care with expert-led, accessible, and actionable content. Join now to transform your approach to T2D management!